| Literature DB >> 30123656 |
Zhi-Guo Liu1,2, Li Bao1, Hong-Wei Liu1, Jin-Wei Ren1, Wen-Zhao Wang1, Long Wang1, Wei Li1,2, Wen-Bing Yin1,2,3.
Abstract
Two new secondary metabolites, kongiilines A and B (1, 7), and twoEntities:
Keywords: Antitumour cell; Tibet; moulds; new compounds; structural elucidation
Year: 2017 PMID: 30123656 PMCID: PMC6059045 DOI: 10.1080/21501203.2017.1331937
Source DB: PubMed Journal: Mycology ISSN: 2150-1203
1H NMR and 13C NMR data for compounds 1 and 7.
| 1a | 7b | ||||
|---|---|---|---|---|---|
| Position | Position | ||||
| 1a | 43.8 | 1.12, m | 2 | 161.6 | |
| 1b | 1.18, m | 3 | 87.5 | 5.65, s | |
| 2a | 18.7 | 1.53, m | 4 | 169.1 | |
| 2b | 1.76, m | 5 | 149.2 | ||
| 3a | 38.3 | 1.20, m | 6 | 107.7 | 7.26, s |
| 3b | 1.69, m | 7 | 131.4 | ||
| 4 | 39.2 | 8 | 143.7 | ||
| 5 | 45.9 | 1.80, m | 9 | 132.1 | |
| 6 | 69.3 | 5.67, m | 10 | 105.9 | |
| 7a | 28.8 | 2.12, m | 11 | 65.4 | 4.67, d (6.5) |
| 7b | 2.47, m | 12 | 119.8 | 5.47, d (6.5) | |
| 8 | 37.0 | 2.87, t (8.0) | 13 | 137.3 | |
| 9 | 50.7 | 2.40, m | 14 | 18.1 | 1.74, s |
| 10 | 35.7 | 15 | 25.5 | 1.76, s | |
| 11a | 69.4 | 4.28,dd (5.5,10) | 16 | 61.2 | 4.80, d (4.0) |
| 11b | 4.47, d (9.5) | 17 | 56.7 | 3.94, s | |
| 12 | 181.2 | ||||
| 13 | 20.3 | 0.88, s | |||
| 14a | 71.2 | 3.03, d (6.5) | |||
| 14b | 3.56, d (6.0) | ||||
| 15 | 19.1 | 1.43, s | |||
| 1′ | 168.1 | ||||
| 2′ | 132.0 | ||||
| 3′ | 130.6 | 7.95,dd (1.5,7.0) | |||
| 4′ | 129.6 | 7.48, d (8.0) | |||
| 5′ | 134.1 | 7.60, t (7.5) | |||
| 6′ | 129.6 | 7.47, d (7.5) | |||
| 7′ | 130.6 | 7.97, dd (1.5,7.0) | |||
aRecorded in MeOD. brecorded in DMSO-d6.
1H NMR and 13C NMR data for compounds 5 and 6.
| 5a | 6b | |||
|---|---|---|---|---|
| Position | ||||
| 1 | 172.2 | 173.3 | ||
| 2 | 54.8 | 4.87, dd (6.5,11.5) | 56.3 | 4.76, dd (6.0,9.0) |
| 3a | 36.9 | 3.12, dd (6.5,14.0) | 37.9 | 3.13, dd (9.0,14.0) |
| 3b | 3.19, dd (6.5,14.0) | 3.27, dd (6.0,9.0) | ||
| 4 | 127.4 | 138.6 | ||
| 5 | 130.5 | 7.04, d (8.5) | 130.5 | 7.26, m |
| 6 | 116.0 | 6.76, d (8.5) | 129.5 | 7.24, m |
| 7 | 155.5 | 127.9 | 7.22, m | |
| 8 | 116.0 | 6.76, d (8.5) | 129.5 | 7.24, m |
| 9 | 130.5 | 7.04, d (8.5) | 130.5 | 7.26, m |
| 10 | 167.7 | 170.3 | ||
| 11 | 134.2 | 125.7 | ||
| 12 | 127.3 | 7.68, d (7.5) | 130.2 | 7.60, d (8.5) |
| 13 | 128.8 | 7.30, t (7.5) | 116.1 | 6.76, d (8.5) |
| 14 | 131.6 | 7.42, t (7.5) | 162.3 | |
| 15 | 128.8 | 7.30, t (7.5) | 116.1 | 6.76, d (8.5) |
| 16 | 127.3 | 7.68, d (7.5) | 130.2 | 7.60, d (8.5) |
| 1′a | 65.5 | 4.03, dd (3.5,11.5) | 66.7 | 4.11, dd (6.0,11.0) |
| 1′b | 4.50, dd (4.5,11.0) | 4.41, dd (4.5,11.0) | ||
| 2′ | 50.5 | 4.60, m | 51.9 | 4.56, m |
| 3′a | 37.4 | 2.90, dd (7.0,14.0) | 37.4 | 2.88, dd (8.5,14.0) |
| 3′b | 3.00, dd (6.5,14.0) | 2.93, dd (6.0,14.0) | ||
| 4′ | 137.2 | 139.1 | ||
| 5′ | 129.4 | 7.22, d (8.0) | 130.3 | 7.25, m |
| 6′ | 128.9 | 7.30, t (7.5) | 129.4 | 7.23, m |
| 7′ | 127.0 | 7.30, t (7.5) | 127.6 | 7.20, m |
| 8′ | 128.9 | 7.24, t (7.5) | 129.4 | 7.23, m |
| 9′ | 129.4 | 7.22, d (8.0) | 130.3 | 7.25, m |
| 10′ | 167.6 | 170.1 | ||
| 11′ | 133.4 | 135.7 | ||
| 12′ | 127.2 | 7.65, d (7.5) | 128.4 | 7.67, d (7.5) |
| 13′ | 128.6 | 7.38, t (7.5) | 127.2 | 7.37, d (7.5) |
| 14′ | 132.2 | 7.50, t (7.5) | 132.6 | 7.49, t (7.5) |
| 15′ | 128.6 | 7.38, t (7.5) | 127.2 | 7.37, d (7.5) |
| 16′ | 127.2 | 7.65, d (7.5) | 128.4 | 7.67, d (7.5) |
aRecorded in DMSO-d6.brecorded in MeOD.
Figure 1.The chemical structures of compounds 1–11 from P. kongii.
Figure 2.The chemical structures of compounds 12–20 from P. brasilianum.
Figure 3.The key HMBC correlations of compounds 1, 5–7.
Cytotoxic activities against HCT116 of 1–11.
| Compound | IC50 ± SD (μM) | Compound | IC50 ± SD (μM) |
|---|---|---|---|
| >100 | >100 | ||
| >100 | >100 | ||
| >100 | >100 | ||
| 88.16 ± 5.52 | 36.92 ± 1.96 | ||
| 77.68 ± 2.84 | >100 | ||
| 91.72 ± 8.31 | Taxol | 0.98 ± 0.12 |